BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

CUSIP: 10806X102

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
191,564,221
Total 13F shares
188,213,795
Share change
+653,290
Total reported value
$14,404,255,681
Put/Call ratio
18%
Price per share
$76.49
Number of holders
427
Value change
+$187,225,304
Number of buys
233
Number of sells
188

Quarterly Holders Quick Answers

What is CUSIP 10806X102?
CUSIP 10806X102 identifies BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) as of Q4 2025

As of 31 Dec 2025, BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) was held by 427 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 188,213,795 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., VIKING GLOBAL INVESTORS LP, Kohlberg Kravis Roberts & Co. L.P., JANUS HENDERSON GROUP PLC, FARALLON CAPITAL MANAGEMENT LLC, Aisling Capital Management LP, STATE STREET CORP, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 427 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.